Treatment of autoinflammatory diseases: results from the Eurofever Registry and a literature review

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Annals of the Rheumatic Diseases

• Publication date

  2012-06-29

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/annrheumdis-2011-201268PMID 22753383
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tonsillectomy for periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis syndrome (PFAPA).

  2014cited by this paper
• Diagnosis of PFAPA syndrome applied to a cohort of 17 adults with unexplained recurrent fevers.

  2012cited by this paper
• Brief report: genotype, phenotype, and clinical course in five patients with PAPA syndrome (pyogenic sterile arthritis, pyoderma gangrenosum, and acne).

  2012cited by this paper
• NLRP 3 E 311 K mutation in a large family with Muckle-Wells syndrome-description of a heterogeneous phenotype and response to treatment

  2012cited by this paper
• Efficacy of etanercept in the tumor necrosis factor receptor-associated periodic syndrome: a prospective, open-label, dose-escalation study.

  2012cited by this paper
• Mevalonate Kinase Deficiency: A Survey of 50 Patients

  2011cited by this paper
• Two-year results from an open-label, multicentre, phase III study evaluating the safety and efficacy of canakinumab in patients with cryopyrin-associated periodic syndrome across different severity phenotypes

  2011cited by this paper
• Efficacy and safety of anakinra therapy in pediatric and adult patients with the autoinflammatory Muckle-Wells syndrome.

  2011cited by this paper
• NLRP3 E311K mutation in a large family with Muckle-Wells syndrome - description of a heterogeneous phenotype and response to treatment

  2011cited by this paper
• Clinical and epidemiological research

  2011cited by this paper
• On-demand anakinra treatment is effective in mevalonate kinase deficiency

  2011cited by this paper
• Effects of Anti-Tumor Necrosis Factor Agents for Familial Mediterranean Fever Patients With Chronic Arthritis and/or Sacroiliitis Who Were Resistant to Colchicine Treatment

  2011cited by this paper
• Clinical Presentation and Pathogenesis of Cold-Induced Autoinflammatory Disease in a Family With Recurrence of an NLRP 12 Mutation

  2011cited by this paper
• Anti-Interleukin 1 Treatment for Patients with Familial Mediterranean Fever Resistant to Colchicine

  2011cited by this paper
• Canakinumab (ACZ885, a fully human IgG1 anti-IL-1β mAb) induces sustained remission in pediatric patients with cryopyrin-associated periodic syndrome (CAPS)

  2011cited by this paper
• Long-term follow-up of children with periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis syndrome.

  2011cited by this paper
• Periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) is a disorder of innate immunity and Th1 activation responsive to IL-1 blockade

  2011cited by this paper
• Interleukin-1 targeting drugs in familial Mediterranean fever: a case series and a review of the literature.

  2011cited by this paper
• Clinical Presentation and Pathogenesis of Cold-Induced Autoinflammatory Disease in a Family With Recurrence of an NLRP12 Mutation

  2011cited by this paper
• The Eurofever Project: towards better care for autoinflammatory diseases

  2011cited by this paper
• Failure of sustained response to etanercept and refractoriness to anakinra in patients with T50M TNF-receptor-associated periodic syndrome

  2011cited by this paper
• Follow-up and quality of life of patients with cryopyrin-associated periodic syndromes treated with Anakinra.

  2010cited by this paper
• PFAPA syndrome in children: A meta-analysis on surgical versus medical treatment.

  2010cited by this paper
• Hyperimmunoglobulin D Syndrome in Childhood

  2010cited by this paper
• Favourable and sustained response to anakinra in tumour necrosis factor receptor-associated periodic syndrome (TRAPS) with or without AA amyloidosis

  2010cited by this paper
• Long-term efficacy of the interleukin-1 receptor antagonist anakinra in ten patients with neonatal-onset multisystem inflammatory disease/chronic infantile neurologic, cutaneous, articular syndrome.

  2010cited by this paper
• Concerted action of wild-type and mutant TNF receptors enhances inflammation in TNF receptor 1-associated periodic fever syndrome

  2010cited by this paper
• Surgical outcomes and histology findings after tonsillectomy in children with periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis syndrome.

  2010cited by this paper
• Outcome of tonsillectomy in selected patients with PFAPA syndrome.

  2009cited by this paper
• Proinflammatory action of the antiinflammatory drug infliximab in tumor necrosis factor receptor-associated periodic syndrome.

  2009cited by this paper
• A clinical review of 105 patients with PFAPA (a periodic fever syndrome)

  2009cited by this paper
• Effectiveness of adenotonsillectomy in PFAPA syndrome: a randomized study.

  2009cited by this paper
• Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease (*).

  2009cited by this paper
• Efficacy and Safety of Canakinumab (ACZ885), a Fully Human Anti-Interleukin-1b-Antibody, in Cryopyrin Associated Periodic Fever Syndrome Results of a Multicenter, Randomized, Double-blind, Phase III Study

  2009cited by this paper
• An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonist.

  2009cited by this paper
• Early suppression of familial Mediterranean fever attacks by single medium dose methyl-prednisolone infusion.

  2008cited by this paper
• Role of Tonsillectomy in PFAPA Syndrome.

  2008cited by this paper
• Effect of adenotonsillectomy in PFAPA syndrome.

  2008cited by this paper
• Interferon-α as a Treatment Modality for Colchicine-Resistant Familial Mediterranean Fever

  2008cited by this paper
• Non-response to colchicine in FMF--definition, causes and suggested solutions.

  2008cited by this paper
• Periodic Fever accompanied by Aphthous stomatitis, Pharyngitis, and cervical Adenitis syndrome (PFAPA syndrome) in adults

  2008cited by this paper
• Colchicine prophylaxis for frequent periodic fever, aphthous stomatitis, pharyngitis and adenitis episodes

  2008cited by this paper
• Use of Anakinra (Kineret) in the Treatment of Familial Cold Autoinflammatory Syndrome with a 16-Month Follow-Up

  2008cited by this paper
• A pilot study to evaluate the safety and efficacy of the long-acting interleukin-1 inhibitor rilonacept (interleukin-1 Trap) in patients with familial cold autoinflammatory syndrome.

  2008cited by this paper
• Long-Term Follow-Up, Clinical Features, and Quality of Life in a Series of 103 Patients With Hyperimmunoglobulinemia D Syndrome

  2008cited by this paper
• Interferon-alpha as a treatment modality for colchicine- resistant familial Mediterranean fever.

  2008cited by this paper
• Efficacy and safety of rilonacept (interleukin-1 Trap) in patients with cryopyrin-associated periodic syndromes: results from two sequential placebo-controlled studies.

  2008cited by this paper
• Persistent efficacy of anakinra in patients with tumor necrosis factor receptor-associated periodic syndrome.

  2008cited by this paper
• Colchicine Use in Children and Adolescents With Familial Mediterranean Fever: Literature Review and Consensus Statement

  2007cited by this paper
• Clinical and functional characterisation of a novel TNFRSF1A c.605T>A/V173D cleavage site mutation associated with tumour necrosis factor receptor-associated periodic fever syndrome (TRAPS), cardiovascular complications and excellent response to etanercept treatment

  2007cited by this paper
• Comment on: Failure of anti-TNF therapy in TNF receptor 1-associated periodic syndrome (TRAPS).

  2007cited by this paper
• Comment on: Failure of anti-TNF therapy in TNF receptor 1-associated periodic syndrome (TRAPS).

  2007cited by this paper
• A randomized, controlled trial of tonsillectomy in periodic fever, aphthous stomatitis, pharyngitis, and adenitis syndrome.

  2007cited by this paper
• Treatment options in colchicine resistant familial Mediterranean fever patients: thalidomide and etanercept as adjunctive agents.

  2006cited by this paper
• Clinical significance of P46L and R92Q substitutions in the tumour necrosis factor superfamily 1A gene

  2006cited by this paper
• Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition.

  2006cited by this paper
• PFAPA syndrome: new clinical aspects disclosed

  2006cited by this paper
• Peculiarities of PAPA syndrome.

  2006cited by this paper
• Phenotype, genotype, and sustained response to anakinra in 22 patients with autoinflammatory disease associated with CIAS-1/NALP3 mutations.

  2006cited by this paper
• The efficacy of continuous interferon alpha administration as an adjunctive agent to colchicine-resistant familial Mediterranean fever patients.

  2004cited by this paper
• Prevention of cold-associated acute inflammation in familial cold autoinflammatory syndrome by interleukin-1 receptor antagonist.

  2004cited by this paper
• The effect of interferon alpha administration on acute attacks of familial Mediterranean fever: A double-blind, placebo-controlled trial.

  2004cited by this paper
• Simvastatin Treatment for Inflammatory Attacks of the Hyperimmunoglobulinemia D and Periodic Fever Syndrome

  2004cited by this paper
• Update on Treatment of Marshall's Syndrome (Pfapa Syndrome): Report of Five Cases with Review of the Literature

  2003cited by this paper
• The enlarging clinical, genetic, and population spectrum of tumor necrosis factor receptor-associated periodic syndrome.

  2002cited by this paper
• The TNF Receptor-Associated Periodic Syndrome (TRAPS): Emerging Concepts of an Autoinflammatory Disorder

  2002cited by this paper
• Limited efficacy of thalidomide in the treatment of febrile attacks of the hyper-IgD and periodic fever syndrome: a randomized, double-blind, placebo-controlled trial.

  2001cited by this paper
• Periodic fever, aphthous stomatitis, pharyngitis, and adenopathy syndrome: clinical characteristics and outcome.

  1999cited by this paper
• The efficacy of interferon alpha on colchicine-resistant familial Mediterranean fever attacks: a pilot study.

  1997cited by this paper
• A new autosomal dominant disorder of pyogenic sterile arthritis, pyoderma gangrenosum, and acne: PAPA syndrome.

  1997cited by this paper
• Protracted febrile myalgia in patients with familial Mediterranean fever.

  1994cited by this paper
• A controlled trial of colchicine in preventing attacks of familial mediterranean fever.

  1974cited by this paper
• Prophylactic colchicine therapy in familial Mediterranean fever. A controlled, double-blind study.

  1974cited by this paper
• Colchicine therapy for familial mediterranean fever. A double-blind trial.

  1974cited by this paper

• Targeting cytokine pathways: the role of biologics in autoinflammatory disorders

  2026cites this paper
• Efficacité de l’amygdalectomie partielle dans le syndrome de fièvre périodique, stomatite, pharyngite et adénopathie : une étude rétrospective observationnelle STROBE

  2025cites this paper
• Therapeutic Approaches for Periodic Fever Syndromes and Autoinflammatory Disorders.

  2025cites this paper
• Familial Mediterranean fever in Romania: a case report and literature review

  2025cites this paper
• Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Cervical Adenitis (PFAPA) Syndrome in Children—From Pathogenesis to Treatment Strategies: A Comprehensive Review

  2025influential citation
• Autoinflammation is a new concept, new nosologies. How to recognize it and what to do?

  2025cites this paper
• Синдром PFAPA (Маршалла) — тактика ведения смешанных специалистов

  2025cites this paper
• Nature-inspired IL-1 targeted therapy to treat chronic inflammatory diseases

  2025cites this paper
• Long-term efficacy and safety of colchicine and anti-IL-1 blockers in FMF: results from the Eurofever multicenter observational study.

  2025cites this paper
• Towards the definition of disease phenotypes in pediatric SAPHO syndrome: a national multicentric study.

  2025cites this paper
• Symptom course of PFAPA syndrome

  2025cites this paper
• Clinical Manifestations and Treatment Response of Patients With Syndrome of Undifferentiated Recurrent Fever (SURF)

  2025cites this paper
• Efficacy and Safety of Anakinra in Colchicine-Resistant or -Intolerant Familial Mediterranean Fever: A Single-Center Real-Life Experience

  2025cites this paper
• Effectiveness of “tumor necrosis factor inhibitors” in monogenic hereditary recurrent fevers in children and adolescents: a systematic review

  2025cites this paper
• Real-World Experience with Canakinumab in Familial Mediterranean Fever: A Single-Center Study

  2025cites this paper
• Monogenic disorders of the TNF signalling pathway

  2025influential citation
• The evolving landscape of rheumatic drugs and their indications in paediatric and adolescent care

  2025cites this paper
• TNF Receptor–Associated Periodic Syndrome: An Analysis of a Slovakian Cohort of TRAPS Patients

  2025cites this paper
• Periodic Fever, Aphthous Stomatitis, Pharyngitis and Adenitis Syndrome: An Update

  2025influential citation
• Corticosteroid use in PFAPA syndrome: clinical practice data from the JIR-CliPS Survey Study and a comprehensive literature review.

  2025cites this paper
• The riddle of recurrent fever: a clinical approach to pediatric autoinflammatory diseases

  2024cites this paper
• A rare missense p.C125Y mutation in the TNFRSF1A gene identified in a Chinese family with tumor necrosis factor receptor-associated periodic fever syndrome

  2024cites this paper
• Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Adenitis (PFAPA) Syndrome: An Overview for Primary Care Practitioners

  2024cites this paper
• Complex MEFV and MVK Variations in a Syrian Child: Implications for Clinical Phenotypes and Treatment Response—A Case Report

  2024cites this paper
• The role of the tonsils in the genesis of PFAPA syndrome: a modern view and description of two clinical cases

  2024cites this paper
• RETRACTED: The Superiority of Compressed Colchicine Tablets over Coated Colchicine Tablets for Familial Mediterranean Fever

  2024influential citation
• Case Report: Identification of a CARD8 variant in all three patients with PFAPA syndrome complicated with Kawasaki disease

  2024cites this paper
• Hereditary periodic fevers in children

  2024cites this paper
• CINCA/NOMID is a rare autoinflammatory syndrome in rheumatological practice. Experience of diagnosis, management and therapy with interleukin-1 inhibitors

  2024cites this paper
• Perioperative care of the patient with a periodic fever syndrome.

  2024cites this paper
• Un cas de syndrome hyper-IgD

  2024cites this paper
• Efficacy of partial tonsillectomy in periodic fever, aphthous stomatitis, pharyngitis and adenitis syndrome: a STROBE retrospective observational study.

  2024cites this paper
• Die häufigsten Fiebersyndrome und autoinflammatorischen Erkrankungen im Erwachsenenalter

  2024cites this paper
• Practical Approach to Diagnosis and Management of IL-1-Mediated Autoinflammatory Diseases (CAPS, TRAPS, MKD, and DIRA)

  2024cites this paper
• A narrative review on the role of cytokines in the pathogenesis and treatment of familial Mediterranean fever: an emphasis on pediatric cases

  2024cites this paper
• Deficiency of Interleukin-1 receptor antagonist: An updated review of the pathogenesis, clinical characteristics, and treatments

  2024cites this paper
• Familial Mediterranean fever and microRNAs

  2023cites this paper
• PFAPA (periodic fever, aphthous stomatitis, pharyngitis, adenitis) syndrome and syndrome of unexplained recurrent fevers in children and adults.

  2023cites this paper
• Efficacy of Anakinra Treatment in two Moroccan Patients With Mevalonate Kinase Deficiency

  2023cites this paper
• Validation of the PEDiatric Behçet’s Disease classification criteria: an evidence-based approach

  2023cites this paper
• Tonsillotomy for Periodic Fever Syndrome: A Randomized and Controlled Trial

  2023cites this paper
• Uveitis Associated with Monogenic Autoinflammatory Syndromes in Children

  2023influential citation
• The use of ketotifen as long-term anti-inflammatory prophylaxis in children with PFAPA syndrome

  2023cites this paper
• PAPA syndrome – diagnostic and therapeutic pa th from pa ediatric to adult rheumatologist

  2023cites this paper
• NLRP12-associated autoinflammatory disease in Chinese adult patients: a single-centre study

  2023cites this paper
• An Update on Familial Mediterranean Fever

  2023cites this paper
• Skin manifestations help identifying different phenotypes of paediatric SAPHO syndrome.

  2023cites this paper
• Long‐Term Efficacy and Safety of Canakinumab in Patients With Tumor Necrosis Factor Receptor–Associated Periodic Syndrome: Results From a Phase III Trial

  2023cites this paper
• Cumhuriyet Medical

  2023cites this paper
• Spectrum of auto-inflammatory diseases in Morocco: a monocentric experience

  2023cites this paper
• Dermatologic Manifestations of Noninflammasome-Mediated Autoinflammatory Diseases

  2022cites this paper
• Treatment in PFAPA Syndrome: A Review

  2022influential citation
• PFAPA syndrome: A practical review

  2022cites this paper
• Hereditary Systemic Autoinflammatory Diseases: Therapeutic Stratification

  2022cites this paper
• Does Pyroptosis Play a Role in Inflammasome-Related Disorders?

  2022cites this paper
• New insights on multigenic autoinflammatory diseases

  2022cites this paper
• Long-term efficacy of tonsillectomy/adenotonsillectomy in patients with periodic fever aphthous stomatitis pharyngitis adenitis syndrome with special emphasis on co-existence of familial Mediterranean fever

  2022cites this paper
• Colchicine versus cimetidine: the better choice for Periodic fever, aphthous stomatitis, pharyngitis, adenitis (PFAPA) syndrome prophylaxis, and the role of MEFV gene mutations

  2022cites this paper
• NLRP3 gene variants and serum NLRP3 levels in periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) syndrome

  2022cites this paper
• An autoinflammatory disease – PFAPA syndrome: a single-center experience

  2022cites this paper
• Characterization of Novel Pathogenic Variants Leading to Caspase-8 Cleavage-Resistant RIPK1-Induced Autoinflammatory Syndrome

  2022cites this paper
• Periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis syndrome in children: a brief literature review

  2022cites this paper
• Efficacy of Canakinumab in a Patient With Adult-Onset Glucocorticoid-Resistant Periodic Fever, Aphthous Stomatitis, Pharyngitis and Cervical Adenitis (PFAPA) Syndrome.

  2022cites this paper
• Síndrome da febre periódica, estomatite aftosa, faringite e adenite em crianças: uma breve revisão de literatura

  2022cites this paper
• The Regulation and Modification of GSDMD Signaling in Diseases

  2022cites this paper
• IL-1 and autoinflammatory disease: biology, pathogenesis and therapeutic targeting

  2022cites this paper
• Efficacy of Anakinra on Multiple Coronary Arteries Aneurysms in an Infant with Recurrent Kawasaki Disease, Complicated by Macrophage Activation Syndrome

  2022cites this paper
• The Preferential Use of Anakinra in Various Settings of FMF: A Review Applied to an Updated Treatment-Related Perspective of the Disease

  2022cites this paper
• Biologic Therapies for the Management of Cutaneous Findings in Genodermatoses: A Review

  2022cites this paper
• Anakinra in Paediatric Rheumatology and Periodic Fever Clinics: Is the Higher Dose Safe?

  2022cites this paper
• Monocyte secretory profiling in a clinical and MEFV genotype-characterized cohort of Danish familial Mediterranean fever patients: diagnostic potential of CCL1 and CXCL1.

  2022cites this paper
• The 2021 EULAR/American College of Rheumatology Points to Consider for Diagnosis, Management and Monitoring of the Interleukin‐1 Mediated Autoinflammatory Diseases: Cryopyrin‐Associated Periodic Syndromes, Tumour Necrosis Factor Receptor‐Associated Periodic Syndrome, Mevalonate Kinase Deficiency, an

  2022cites this paper
• Interventions for reducing inflammation in familial Mediterranean fever.

  2022cites this paper
• The efficacy and safety of allogeneic stem cell transplantation in Mevalonate Kinase Deficiency

  2022cites this paper
• The 2021 EULAR/American College of Rheumatology points to consider for diagnosis, management and monitoring of the interleukin-1 mediated autoinflammatory diseases: cryopyrin-associated periodic syndromes, tumour necrosis factor receptor-associated periodic syndrome, mevalonate kinase deficiency, an

  2022cites this paper
• The impact of the Eurofever criteria and the new InFevers MEFV classification in real life: Results from a large international FMF cohort.

  2022cites this paper
• Autoinflammatory syndromes in neurology: when our first line of defence misbehaves

  2021cites this paper
• Quando suspeitar de doenças autoinflamatórias na infância?

  2021cites this paper
• Treating Type 2 Autoimmune Pancreatitis With Colchicine: A Case Series

  2021cites this paper
• Biological disease-modifying antirheumatic drugs in the main monogenic autoinflammatory diseases treatment. Experience of application in rheumatological practice

  2021cites this paper
• Activation of GSDME compensates for GSDMD deficiency in a mouse model of NLRP3 inflammasomopathy

  2021cites this paper
• Treatment of Autoinflammatory Diseases

  2021cites this paper
• IL-1 Inhibitors in the Treatment of Monogenic Periodic Fever Syndromes: From the Past to the Future Perspectives

  2021cites this paper
• Renal AA Amyloidosis as Rare Presentation of Tumor Necrosis Factor Receptor−Associated Periodic Syndrome in Pediatric Patient

  2021cites this paper
• Mevalonate kinase deficiency syndrome: Single center experience

  2021cites this paper
• NLRP3 inflammasome activation triggers gasdermin D–independent inflammation

  2021cites this paper
• Immune Dysfunction and Drug Targets in Autoinflammatory Syndromes

  2021cites this paper
• Periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) syndrome: A review

  2021cites this paper
• Compromised Protein Prenylation as Pathogenic Mechanism in Mevalonate Kinase Deficiency

  2021cites this paper
• Colchicine – an effective treatment for children with a clinical diagnosis of autoinflammatory diseases without pathogenic gene variants

  2021cites this paper
• The combined prevalence of classified rare rheumatic diseases is almost double that of ankylosing spondylitis

  2021cites this paper
• Next Generation Sequencing Based Multiplex Long-Range PCR for Routine Genotyping of Autoinflammatory Disorders

  2021cites this paper
• Monogenic Autoinflammatory Diseases: State of the Art and Future Perspectives

  2021influential citation
• Twists and turns of the genetic story of mevalonate kinase-associated diseases: A review

  2021cites this paper
• Recall Injection-Site Reactions After Treatment With Anakinra.

  2021influential citation
• Anakinra and canakinumab for patients with R92Q-associated autoinflammatory syndrome: a multicenter observational study from the AIDA Network

  2021cites this paper
• Biotechnological Agents for Patients With Tumor Necrosis Factor Receptor Associated Periodic Syndrome—Therapeutic Outcome and Predictors of Response: Real-Life Data From the AIDA Network

  2021cites this paper
• The challenge of early diagnosis of autoimmune lymphoproliferative syndrome in children with suspected autoinflammatory/autoimmune disorders.

  2021cites this paper
• Biologic disease-modifying antirheumatic drugs in the treatment of major monogenic autoinflammatory diseases: literature review and clinical observation

  2021cites this paper
• TRAPS bei Kindern und Jugendlichen

  2021cites this paper